PAMCX
Price
$92.91
Change
-$0.20 (-0.21%)
Updated
Jun 2 closing price
Net Assets
23.23B
PNOTX
Price
$19.51
Change
+$0.12 (+0.62%)
Updated
Jun 2 closing price
Net Assets
333.94M
Interact to see
Advertisement

PAMCX vs PNOTX

Header iconPAMCX vs PNOTX Comparison
Open Charts PAMCX vs PNOTXBanner chart's image
PAMCX vs PNOTX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. PNOTX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Buy and PNOTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 23.2B vs. PNOTX (334M). PAMCX (0.00) and PNOTX (0.00) have matching dividends . PAMCX was incepted earlier than PNOTX: PAMCX (26 years) vs PNOTX (8 years). PAMCX (1.02) is less costly to investors than PNOTX (0.66). PNOTX is a more actively managed with annual turnover of: 80.00 vs. PAMCX (31.50). PNOTX has a lower initial minimum investment than PAMCX: PNOTX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : 1.95 vs. PNOTX (-5.00). PAMCX return over 5 years is better than : -18.38 vs. PNOTX (-26.27).
PAMCXPNOTXPAMCX / PNOTX
Total Expense Ratio1.020.66155%
Annual Report Gross Expense Ratio1.020.66155%
Fund Existence26 years8 years-
Gain YTD2.2963.85660%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.2B334M6,946%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.95-5.00-39%
Returns for 3 years2.0813.4615%
Returns for 5 years-18.38-26.2770%
Returns for 10 years26.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPATU11.420.54
+4.96%
GP-Act III Acquisition Corp
EMN76.671.18
+1.56%
Eastman Chemical Company
VOC2.990.03
+1.01%
VOC Energy Trust
STOK28.68-1.79
-5.87%
Stoke Therapeutics
RGNX6.52-0.62
-8.68%
REGENXBIO